Azacitidine
Pevonedistat-1016
Phase 2 small_molecule completed
Quick answer
Azacitidine for Myelodysplastic Syndromes is a Phase 2 program (small_molecule) at Takeda with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Myelodysplastic Syndromes
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed